NeuroSense Therapeutics Ltd

NEW
FRA:H1Z (Israel)  
€ 0.28 +0.0040 (+1.44%) Aug 20
At Loss
Market Cap:
€ 11.34M ($ 13.24M)
Enterprise V:
€ 11.34M ($ 13.24M)
Volume:
60.00
Avg Vol (2M):
2.00K
Trade In:

NeuroSense Therapeutics Ltd (FRA:H1Z) Dividend

NeuroSense Therapeutics Ltd (FRA:H1Z) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -40.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:H1Z Dividend

Does NeuroSense Therapeutics Ltd (FRA:H1Z) pay a dividend?

NeuroSense Therapeutics Ltd (FRA:H1Z) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't NeuroSense Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. NeuroSense Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -40.3% over the past 3 years.

What are dividend-paying alternatives to NeuroSense Therapeutics Ltd?

For dividend-paying alternatives in NeuroSense Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.